Tokyo Veterinary Cardiology Center, Tokyo, Japan.
Yokohama Yamate Dog & Cat Medical Center, Kanagawaken, Japan.
Open Vet J. 2021 Jul-Sep;11(3):342-345. doi: 10.5455/OVJ.2021.v11.i3.2. Epub 2021 Jul 10.
The use of thiazide diuretics is recommended in the American College of Veterinary Internal Medicine guidelines for advanced heart failure due to mitral insufficiency (MI) in dogs. However, there are no large-scale reports of the use of thiazide diuretics in dogs with advanced heart failure.
This retrospective study evaluated the therapeutic effect of concomitant hydrochlorothiazide (HTCZ) with loop diuretics in dogs with heart failure.
The study included 14 dogs diagnosed with advanced pulmonary edema with MI at two facilities. In all cases, high-dose loop diuretics (torsemide; 0.78-4 mg/kg/day) did not improve pulmonary edema. The results of the echocardiography and renal function tests before and after the administration of HTCZ (0.2-0.84 mg/kg/day) in addition to torsemide were statistically compared.
The echocardiographic data demonstrated significant improvement in relation to cardiac stress; left atrium to the aorta ratio, normalized left ventricular internal dimension in diastole, and E wave velocity () after HTCZ administration. However, blood urea nitrogen and creatinine levels increased, and potassium levels decreased, indicating a decline in renal function following HTCZ administration.
This study suggests that the administration of HTCZ in combination with loop diuretics may be beneficial during advanced heart failure due to MI in dogs. The results can also be extended to patients who are resistant to loop diuretics, resulting in the improvement of cardiac function. However, as the combination of HTCZ and loop diuretics can deteriorate renal function, caution should be exercised prior to making recommendations regarding its use, and renal function should be monitored.
美国兽医内科学会的指南建议在犬二尖瓣关闭不全(MI)引起的晚期心力衰竭中使用噻嗪类利尿剂。然而,目前还没有关于噻嗪类利尿剂在晚期心力衰竭犬中使用的大规模报告。
本回顾性研究评估了同时使用氢氯噻嗪(HTCZ)和袢利尿剂治疗心力衰竭犬的疗效。
该研究纳入了两家机构的 14 只诊断为 MI 合并晚期肺水肿的犬。在所有病例中,高剂量袢利尿剂(托塞米;0.78-4mg/kg/天)并未改善肺水肿。比较了在使用 HTCZ(0.2-0.84mg/kg/天)联合托塞米前后的超声心动图和肾功能检查结果。
超声心动图数据显示,在 HTCZ 给药后,心脏应激相关的左心房至主动脉比、正常化舒张期左室内径和 E 波速度()显著改善。然而,血尿素氮和肌酐水平升高,钾水平下降,提示 HTCZ 给药后肾功能下降。
本研究表明,在犬 MI 引起的晚期心力衰竭中,联合使用 HTCZ 和袢利尿剂可能有益。该结果也可扩展至对袢利尿剂耐药的患者,从而改善心功能。然而,由于 HTCZ 与袢利尿剂的联合使用可能会恶化肾功能,因此在推荐其使用之前应谨慎,并应监测肾功能。